76 related articles for article (PubMed ID: 14670993)
1. Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development.
Colomer JM; Terasawa M; Means AR
Endocrinology; 2004 Mar; 145(3):1356-66. PubMed ID: 14670993
[TBL] [Abstract][Full Text] [Related]
2. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.
Gruver CL; DeMayo F; Goldstein MA; Means AR
Endocrinology; 1993 Jul; 133(1):376-88. PubMed ID: 8319584
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral expression of calmodulin antisense reduces hypertrophy in cultured cardiomyocytes.
Arruda LH; Cestari IA; Leirner AA; Cestari IN
Artif Organs; 2007 Apr; 31(4):274-7. PubMed ID: 17437495
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin regulation of excitation-contraction coupling in cardiac myocytes.
Yang D; Song LS; Zhu WZ; Chakir K; Wang W; Wu C; Wang Y; Xiao RP; Chen SR; Cheng H
Circ Res; 2003 Apr; 92(6):659-67. PubMed ID: 12609973
[TBL] [Abstract][Full Text] [Related]
6. E2F4 is required for cardiomyocyte proliferation.
van Amerongen MJ; Diehl F; Novoyatleva T; Patra C; Engel FB
Cardiovasc Res; 2010 Apr; 86(1):92-102. PubMed ID: 19955219
[TBL] [Abstract][Full Text] [Related]
7. IGF signaling directs ventricular cardiomyocyte proliferation during embryonic heart development.
Li P; Cavallero S; Gu Y; Chen TH; Hughes J; Hassan AB; Brüning JC; Pashmforoush M; Sucov HM
Development; 2011 May; 138(9):1795-805. PubMed ID: 21429986
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte growth regulation by Ca(2+)-calmodulin.
Graver CL; George SE; Means AR
Trends Cardiovasc Med; 1992; 2(6):226-31. PubMed ID: 21239246
[TBL] [Abstract][Full Text] [Related]
9. Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
Fukuda M; Yamamoto T; Nishimura S; Kato T; Murakami W; Hino A; Ono M; Tateishi H; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
Biochem Biophys Res Commun; 2014 May; 448(1):1-7. PubMed ID: 24755079
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei.
Walsh S; Pontén A; Fleischmann BK; Jovinge S
Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cardiomyocyte polyploidy and multinucleation by CyclinG1.
Liu Z; Yue S; Chen X; Kubin T; Braun T
Circ Res; 2010 May; 106(9):1498-506. PubMed ID: 20360255
[TBL] [Abstract][Full Text] [Related]
12. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression.
Colomer JM; Means AR
Mol Endocrinol; 2000 Aug; 14(8):1125-36. PubMed ID: 10935538
[TBL] [Abstract][Full Text] [Related]
13. [Polyploidy: significance for cardiomyocyte function and heart aerobic capacity].
Anatskaia OV; Vinogradov AE
Tsitologiia; 2004; 46(2):105-13. PubMed ID: 15174349
[TBL] [Abstract][Full Text] [Related]
14. Left and right ventricular contributions to the formation of the interventricular septum in the mouse heart.
Franco D; Meilhac SM; Christoffels VM; Kispert A; Buckingham M; Kelly RG
Dev Biol; 2006 Jun; 294(2):366-75. PubMed ID: 16677630
[TBL] [Abstract][Full Text] [Related]
15. Nuclear targeting of Akt enhances ventricular function and myocyte contractility.
Rota M; Boni A; Urbanek K; Padin-Iruegas ME; Kajstura TJ; Fiore G; Kubo H; Sonnenblick EH; Musso E; Houser SR; Leri A; Sussman MA; Anversa P
Circ Res; 2005 Dec; 97(12):1332-41. PubMed ID: 16293788
[TBL] [Abstract][Full Text] [Related]
16. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
[TBL] [Abstract][Full Text] [Related]
17. miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B; Chen S; George B; Feng Q; Chakrabarti S
Diabetes Metab Res Rev; 2010 Jan; 26(1):40-9. PubMed ID: 20013939
[TBL] [Abstract][Full Text] [Related]
18. Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death.
Huang F; Wagner M; Siddiqui MA
Mech Dev; 2004 Jun; 121(6):559-72. PubMed ID: 15172687
[TBL] [Abstract][Full Text] [Related]
19. Cell history determines the maintenance of transcriptional differences between left and right ventricular cardiomyocytes in the developing mouse heart.
Kelly RG; Lemonnier M; Zaffran S; Munk A; Buckingham ME
J Cell Sci; 2003 Dec; 116(Pt 24):5005-13. PubMed ID: 14625394
[TBL] [Abstract][Full Text] [Related]
20. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
